PaperAPC resistance in neonates and infants: Adjustment of the aPTT - based method
References (16)
- et al.
Impairment of the protein C anticoagulant pathway in a patient with systemic lupus crythematosus, anticardiolipin antibodies and thrombosis
Thromb Res
(1990) - et al.
Venous thrombosis due to poor anticoagulant response to activated protein C. Leiden Thrombophilia Study
Lancet
(1993) - et al.
Modified test for activated protein C resistance
Lancet
(1994) - et al.
Modified APC resistance assay for patients on oral anticoagulants
Lancet
(1994) - et al.
Resistance to activated protein C: evaluation of three functional assays
Thromb Res
(1994) - et al.
Factor VIII defect associated with familial thrombophilia
Thromb Haemostas
(1991) - et al.
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C
- et al.
Mutation in blood coagulation factor V associated with resistance to activated protein C
Nature
(1994)
There are more references available in the full text version of this article.
Cited by (29)
Laboratory Evaluation of Hypercoagulability
2009, Clinics in Laboratory MedicineCitation Excerpt :In newborns, a 1:11 dilution performed better than a 1:5 dilution. Furthermore, the 1:11 dilution results correlate with DNA analysis, whereas the 1:5 dilution results did not.75 Therefore, optimum assessment of activated protein C resistance in newborns may require a 1:11 dilution in factor V–deficient plasma.
Hemostatic Disorders of the Newborn
2005, Avery's Diseases of the NewbornHypercoagulability test strategies in the protein C and protein S pathway
2002, Clinics in Laboratory MedicineLaboratory evaluation of hypercoagulable states
1998, Hematology/Oncology Clinics of North AmericaThromboembolism and resistance to activated protein C in children with underlying cardiac disease
1996, Journal of Pediatrics
Copyright © 1996 Published by Elsevier Ireland Ltd.